De Vera, Dante E.

HRN: 27-22-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
CLINDAMYCIN 300MG (CAP)
07/17/2026
07/23/2026
PO
300mg
TID
Cellulitis
Checking Final Appropriateness 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: